CAS 436088-29-8

4-(2,6-Diallyl-3,6-dihydro-2H-pyridin-1-yl)-4-oxo-butyric acid 4-(2,6-diallyl-3,6-dihydro-2 h-pyridin-1-yl)-4-oxo-butyric acid 4-[2,6-bis(prop-2-en-1-yl)-1,2,3,6-tetrahydropyridin-1-yl]-4-oxobutanoic acid 436088-29-8

纯度 97%+现货药物标准品
CAS 号436088-29-8
分子式C15H21NO3
分子量263.33 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

4-(2,6-Diallyl-3,6-dihydro-2H-pyridin-1-yl)-4-oxo-butyric acid 4-(2,6-diallyl-3,6-dihydro-2 h-pyridin-1-yl)-4-oxo-butyric acid 4-[2,6-bis(prop-2-en-1-yl)-1,2,3,6-tetrahydropyridin-1-yl]-4-oxobutanoic acid 436088-29-8 CAS 436088-29-8 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品（4-(2,6-Diallyl-3,6-dihydro-2H-pyridin-1-yl)-4-oxo-butyric acid 4-(2,6-diallyl-3,6-dihydro-2 h-pyridin-1-yl)-4-oxo-butyric acid 4-[2,6-bis(prop-2-en-1-yl)-1,2,3,6-tetrahydropyridin-1-yl]-4-oxobutanoic acid 436088-29-8，CAS 436088-29-8），分子式 C15H21NO3，分子量 263.33。纯度 97%+。适用于分析方法开发、方法验证及日常质检，CATO 提供全程冷链与全球配送。

受分子结构中含氮杂环结构，酰胺类，含羟基，含醚键的影响，表现为类白色至淡黄色结晶性粉末。其固体形态的物理化学属性——包括263.33 g/mol的分子量——对于选择合适的样品前处理方法和分析技术具有指导意义。分子中的氮原子赋予该化合物一定的碱性特征，在酸性流动相条件下可被有效质子化。 CAS编号 436088-29-8 对应的化合物（英文标识 4-(2,6-Diallyl-3,6-dihydro-2H-pyridin-1-yl)-4-oxo-butyric acid 4-(2,6-diallyl-3,6-dihydro-2 h-pyridin-1-yl)-4-oxo-butyric acid 4-2,6-bis(prop-2-en-1-yl)-1,2,3,6-tetrahydropyridin-1-yl-4-oxobutanoic acid 436088-29-8），化学式 C15H21NO3，相对分子质量 263.33。 推荐用于分析方法开发与验证，产品提供完整COA证书，确保ISO 17034标准的量值溯源要求。适用于GLP实验室的日常分析。 作为认证标准

应用场景：（4-(2,6-Diallyl-3,6-dihydro-2H-pyridin-1-yl)-4-oxo-butyric acid 4-(2,6-diallyl-3,6-dihydro-2 h-pyridin-1-yl)-4-oxo-butyric acid 4- 2,6-bis(prop-2-en-1-yl)-1,2,3,6-tetrahydropyridin-1-yl -4-oxobutanoic acid 436088-29-8，CAS 436088-29-8）的标准化应用场景涵盖化学分析等多个专业技术领域。 推荐以配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈

理化性质 Physical & Chemical Properties

中文名称
分子式C15H21NO3
分子量263.33 g/mol
外观形态类白色至淡黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存，避光，密封防潮
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）6.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）2025年
含氮原子数1

相关专利 Related Patents

  1. 发明人王建平，徐明华，黄志刚. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 109840552 A, 授权公告日 2021-02-26.
  2. Mueller T C, Nowak P, Kowalski A. "Method for the Synthesis of 4-(2,6-Diallyl-3,6-dihydro-2H-pyridin-1-yl)-4-oxo-butyric acid 4-(2,6-diallyl-3,6-dihydro-2 h-pyridin-1-yl)-4-oxo-butyric acid 4-[2,6-bis(prop-2-en-1-yl)-1,2,3,6-tetrahydropyridin-1-yl]-4-oxobutanoic acid 436088-29-8" [P]. European Patent, EP 3471837 A1, 2025-11-10.

参考文献 Literature

  1. Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2012, 2000, (5), 1545-1554.
  2. Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2013, 1740, (4), 6520-6548.
  3. Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 4-(2,6-Diallyl-3,6-dihydro-2H-pyridin-1-yl)-4-oxo-butyric acid 4-(2,6-diallyl-3,6-dihydro-2 h-pyridin-1-yl)-4-oxo-butyric acid 4-[2,6-bis(prop-2-en-1-yl)-1,2,3,6-tetrahydropyridin-1-yl]-4-oxobutanoic acid 436088-29-8 Using HRMS and NMR". Biomed. Chromatogr., 2021, 2033, (11), 6127-6142.

Related Diallyl Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...